VStar Capital is a China-based investment firm focusing on growth-stage opportunities. The firm primarily targets Series C rounds, demonstrating a preference for companies with established traction and scalable business models. VStar Capital's investment strategy appears to be centered on companies with high growth potential in the Chinese market.
One of VStar Capital's notable portfolio companies is Genetron Health, a precision oncology platform that has raised $61 million in funding. This investment showcases VStar's interest in the healthcare and biotechnology sectors, particularly in companies leveraging advanced technologies to address critical medical needs. VStar Capital likely provides strategic guidance and industry connections to help its portfolio companies expand in the Chinese market.
VStar Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series C1 (100.0%)
Stage Mix
Series C 100%
Concentration shown as share of disclosed investments by stage.
